The following represents disclosure information provided by authors of this abstract. The program committee has reviewed all presenting author disclosure reports, identified potential conflicts of interest, and implemented strategies to manage those areas of conflict, where appropriate. All relationships are considered compensated. Relationships are self-held unless otherwise noted. I = Immediate Family Member, Inst = My Institution
 
Open Payments is a public database containing information reported by companies about payments made to US-licensed physicians (Open Payments)
 
 
Stock and Other Ownership Interests - Actinium Pharmaceuticals; Cellectar
Risk for SARS-CoV-2 infection in patients with breast cancer treated with chemotherapy, biologic therapy or active surveillance: Patient outcomes from multicenter institution in New York.
 
Nibash Budhathoki
No Relationships to Disclose
 
John Kucharczyk
No Relationships to Disclose
 
Nina D'Abreo
No Relationships to Disclose
 
Maryann J. Kwa
Research Funding - Bristol-Myers Squibb (Inst)
 
Magdalena Plasilova
No Relationships to Disclose
 
Shubhada Dhage
No Relationships to Disclose
 
Alexander A. Hindenburg
Employment - NYU School of Medicine
Consulting or Advisory Role - bioTheranostics
Expert Testimony - Lancet Oncology
 
Joanna Lee
No Relationships to Disclose
 
Megan Winner
No Relationships to Disclose
 
Alison Daly
No Relationships to Disclose
 
Phyu Phyu Soe
No Relationships to Disclose
 
Angela Ramdhanny
No Relationships to Disclose
 
Freya Ruth Schnabel
No Relationships to Disclose
 
Ruth Oratz
No Relationships to Disclose
 
James L. Speyer
No Relationships to Disclose
 
Yelena Novik
No Relationships to Disclose
 
Marleen Iva Meyers
No Relationships to Disclose
 
Simon Jones
Employment - Methods Analytics
Leadership - Methods Analytics
Stock and Other Ownership Interests - Methods Analytics
 
Sylvia Adams
Consulting or Advisory Role - Bristol-Myers Squibb; Genentech; Merck
Research Funding - Amgen (Inst); Bristol-Myers Squibb (Inst); Celgene (Inst); Genentech (Inst); Merck (Inst); Novartis (Inst)
 
Douglas Kanter Marks
Speakers' Bureau - MJH Healthcare Holdings, LLC
Research Funding - Agendia
Travel, Accommodations, Expenses - Agendia